乳腺癌的治疗进展

被引：15

作者：

杜珍 ^{[1
]}

陆倍倍 ^{[2
]}

张沂 ^{[1
]}

机构：

[1] 海军总医院

[2] 军事医学科学院放射与辐射医学研究所

来源：

海军医学杂志 | 2007年 / 04期

关键词：

乳腺癌; 化疗; 内分泌治疗; 靶向治疗;

D O I：

暂无

中图分类号：

R737.9 [乳腺肿瘤];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：367 / 369

页数：3

共 9 条

[1]

国际乳腺癌研究新进展——第28届圣安东尼奥乳腺癌学术研讨会报道 [J].

张保宁 ;

王仲照 .

中华医学杂志, 2006, (08) :573-576

[2]

单药希罗达治疗复发转移性乳腺癌的疗效观察.[J].王涛;江泽飞;宋三泰;张少华;申戈;于静新.中华肿瘤杂志.2004, 06

[3]

泰索帝联合希罗达治疗蒽环类化疗失败复发转移性乳腺癌的临床研究 [J].

张少华 ;

江泽飞 ;

宋三泰 ;

申戈 ;

王涛 ;

曾敏 ;

郭中宁 .

癌症进展, 2004, (03) :217-220

[4]

Review of the development of letrozole and its use in advanced breast cancer and in the neoadjuvant setting.[J].A.S. Bhatnagar.The Breast.2006, 1

[5]

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials [J].

Abe, O ;

Abe, R ;

Enomoto, K ;

Kikuchi, K ;

Koyama, H ;

Masuda, H ;

Nomura, Y ;

Sakai, K ;

Sugimachi, K ;

Tominaga, T ;

Uchino, J ;

Yoshida, M ;

Haybittle, JL ;

Davies, C ;

Harvey, VJ ;

Holdaway, TM ;

Kay, RG ;

Mason, BH ;

Forbes, JF ;

Wilcken, N ;

Gnant, M ;

Jakesz, R ;

Ploner, M ;

Yosef, HMA ;

Focan, C ;

Lobelle, JP ;

Peek, U ;

Oates, GD ;

Powell, J ;

Durand, M ;

Mauriac, L ;

Di Leo, A ;

Dolci, S ;

Piccart, MJ ;

Masood, MB ;

Parker, D ;

Price, JJ ;

Hupperets, PSGJ ;

Jackson, S ;

Ragaz, J ;

Berry, D ;

Broadwater, G ;

Cirrincione, C ;

Muss, H ;

Norton, L ;

Weiss, RB ;

Abu-Zahra, HT ;

Portnoj, SM ;

Baum, M ;

Cuzick, J .

LANCET, 2005, 365 (9472) :1687-1717

[6]

Adjuvant therapy of breast cancer with docetaxel-containing combination (TAC) — A Hungarian experience in the BCIRG 001 trial.[J].Katalin Boér;István L↭g;Éva Juhos;Tamás Pintér;János Szántó.Pathology Oncology Research.2003, 3

[7]

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial [J].

Baum, M ;

Buzdar, AU ;

Cuzick, J ;

Forbes, J ;

Houghton, J ;

Klijn, JGM ;

Sahmoud, T .

LANCET, 2002, 359 (9324) :2131-2139

[8]

HER2/ neu as a Predictive Factor in Breast Cancer.[J].Caroline Lohrisch;Martine Piccart.Clinical Breast Cancer.2001, 2

[9]

Economic Evaluation of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in Canada.[J].Mark Nuijten;John McCormick;Franz Waibel;Diana Parison.Value in Health.2000, 1

← 1 →